NBA DFS Picks for FanDuel and DraftKings – 3/19/17

Welcome to another edition of ResearchFantasy’s NBA Breakdown. These picks are what I consider to be the best play of the day, relative to their price. One of the most important things we must consider in daily fantasy is how many points a player gets per dollar. It helps us identify value plays to pair with studs that we know will produce in order to maximize our potential points in lineups. I also try to identify plays that can be used in either cash games or tournaments. Typically, when I build my cash games, I am looking for players that have the best floor combined with good upside. If you have any questions, comments or suggestions, please let us know!

Pricing is FantasyDraft/FanDuel/DraftKings


Ricky Rubio (13800/7500/7500) – Let’s get one thing out of the way: it’s going to be an ongoing effort to figure this slate out. Facing inferior competition and winding the year down, both the Cavs and Spurs could rest players. If this is announced early enough in the day, I will update it. I am going to proceed for both cases. Let’s start with someone who has nothing to do with either game. Rubio has been playing awesome ball, and even a very tough matchup against the Miami Heat didn’t completely slow him down. It did enough that he didn’t have another 40 point game, but he still did OK. I think the matchup here against the Pelicans is a great chance for him to bounce back to that level of play.

Deron Williams (9100/4000/4600) – Kyrie Irving was questionable for Saturday night [at the time of this writing I don’t know if he ends up playing or not]. I would have to imagine the Cavs play it safe and keep him sidelined against the lowly Lakers. That would mean Deron Williams would get a fairly reasonable run. His price is fair for what he would have the opportunity to do. The Lakers are horrible, and that really just can’t be stated enough. Williams has 30 point upside even in limited time if he’s starting tonight, and really doesn’t make a horrible punt play if he doesn’t.


DeMar DeRozan (14300/8800/7700) – It’s so crazy to think that we are in a situation where DeRozan is under $8k on DraftKings, Kyle Lowry is out and we really have to question if he makes for a good play or not. Teams are double teaming him like crazy right now because they know no one else is doing anything on the offensive side of the ball. Eventually, though, something is going to give way. A team like the Pacers who aren’t the most impressive team defensively could be just the medicine DeRozan needs in order to get back on track.

Josh Richardson (9100/4100/4600) – It looks like Dion Waiters is going to be out for awhile. The question now becomes who will benefit in terms of minutes, and then production because they are not correlated to position. Wayne Ellington is a more likely producer without Waiters on the floor, but Josh Richardson is likely to see a ton more minutes. He also does more than Ellington does as well. The price isn’t too much at all for someone who has some 30 point games under his belt earlier this season.


Kawhi Leonard (17900/9900/10000) – I am going to move forward as if for now that the Spurs will not be resting their starters, but Greg Popovich is going to Greg Popovich. The Kings are just the type of team that Kawhi is going to be overused against, but then again, some might look at the inflated price, think of the blowout potential and move on to the next. Strange things happen in the world of basketball, and an on paper blowout can quickly become a hotly contested game. He’s got huge upside, but let’s make sure he’s playing tonight.

Brandon Ingram (9800/4400/4900) – Brandon Ingram had the best game of his young career against the Cavs a few months back, and now the Cavs will be traveling to his home court to take on the Lakers. Ingram is going to see at least 35 minutes unless he fouls out. Luke Walton really wants to work at developing him now that the season is fully, totally and completely lost. He’s got enough upside that I think he should be worth putting in your lineup tonight.


Anthony Davis (19200/11400/10800) – One game that we know should stay closely contested is the Minnesota/New Orleans game, so it probably wouldn’t be a bad idea to have some exposure to that. Davis is the safest of the elements on this Pelicans team, and that is saying something considering his lengthy injury history. I think he should be a good bet to have a strong game tonight, and his price really isn’t as bad as it could be.

Skal Labissiere (8800/4200/4500) – Skal has been someone I’ve used off and on since the All-Star Break, and tonight seems like one of the worst possible nights to go back to the well. Unfortunately, we don’t have a lot of alternatives being that it is such a short slate, and on top of that, value is very thin. There is always a chance that the Spurs don’t come out firing, and the Kings can stay in this. Even if they don’t, I think Skal should see the time necessary to put up enough of a game to hit value.


Karl-Anthony Towns (18300/10500/10300) – With or without DeMarcus Cousins, I do not mind using KAT tonight. How can one be adverse to using him, anyway? He’s one of the best producers in the league, and even though he’s extremely expensive, he offers a pretty safe floor and a very high ceiling. On a short slate, especially if the Cavs and Spurs are out, you’ll have to spend up somewhere, so I wouldn’t be shocked to see high ownership on him.

Jusuf Nurkic (12600/6300/6700) – Nurkic is a nice option that can really explode from time to time. He’s priced reasonably across the board, which really makes him attractive on a night like tonight. Miami can be beat through the center position, and with Hassan Whiteside banged up, Nurkic could really work him over tonight.

Slate Strategy

I’ll update this a little more in the morning, but the general idea is we need to wait to see if the Cavs or Spurs rest some of their starters. If by noon I haven’t heard anything, I’ll put together a more thorough breakdown.

Thanks for reading! Don’t ever hesitate to reach out in the comments, follow us on Twitter @researchandwin or email us at!